IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 228 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Arctis Global LLC | 87,331 | $397,356 | 0.22% |
| Anson Funds Management LP | 200,000 | $910,000 | 0.18% |
| QVT Financial LP | 678,564 | $3,087,466 | 0.18% |
| Intellectus Partners, LLC | 120,279 | $547,267 | 0.17% |
| SEVEN EIGHT CAPITAL, LP | 319,502 | $1,453,734 | 0.17% |
| Brevan Howard Capital Management LP | 1,562,686 | $7,110,221 | 0.09% |
| Candriam S.C.A. | 2,747,853 | $12,502,732 | 0.09% |
| 683 Capital Management, LLC | 250,000 | $1,137,500 | 0.09% |
| C WorldWide Group Holding A/S | 1,360,000 | $6,188 | 0.08% |
| ALGERT GLOBAL LLC | 393,776 | $1,792 | 0.08% |
| Zimmer Partners, LP | 588,000 | $2,675,400 | 0.07% |
| ROANOKE ASSET MANAGEMENT CORP/ NY | 35,300 | $161 | 0.07% |
| PROFUND ADVISORS LLC | 250,510 | $1,139,821 | 0.06% |
| HARBOR CAPITAL ADVISORS, INC. | 64,863 | $295,127 | 0.06% |
| Caption Management, LLC | 874,300 | $3,978,065 | 0.06% |
| Hennion & Walsh Asset Management, Inc. | 180,495 | $821,252 | 0.05% |
| BALYASNY ASSET MANAGEMENT L.P. | 4,476,836 | $20,369,604 | 0.04% |
| Pekin Hardy Strauss, Inc. | 56,000 | $254,800 | 0.04% |
| Rafferty Asset Management, LLC | 1,496,170 | $6,807,574 | 0.04% |
| Pictet Asset Management Holding SA | 6,913,684 | $31,457,262 | 0.04% |
External links
This page lists IOVANCE BIOTHERAPEUTICS INC's shareholders in Q3 2023. To view IOVANCE BIOTHERAPEUTICS INC's shareholder history, click here.